Navigation Links
DHEA-S RIA Test

ProductsDHEA-S RIA Test
Company Diagnostic Systems Laboratories, Inc.
Item DHEA-S RIA Test
Features 
Description Dehydroepiandrosterone sulfate (DHEA-S) is the sulfate ester of DHEA, derived from sulfated precursors and by enzymatic conversion of DHEA in adrenal and extradrenal tissues. DHEA is the major C19 steroid secreted by the adrenal cortex, and is a precursor for testosterone and estrogen biosynthesis. DHEA possesses relatively weak androgenic activity, which for unsulfated DHEA has been estimated at ~10% that of testosterone [1]. However, the bioactivity of DHEA-S may be increased by its relatively high serum concentrations, approximately 100 to 1000-fold higher than DHEA or testosterone, and its weak affinity for its binding protein, sex-hormone binding globulin [2].

Measurement of serum DHEA-S is a useful marker of adrenal androgen synthesis. Abnormally low levels may occur in have been reported in hypoadrenalism [3], while elevated levels occur in several conditions [2,4], e.g. virilizing adrenal adenoma and carcinoma, 21-hydroxylase and 3-hydroxysteroid dehydrogenase deficiencies and in some cases of female hirsutism. As very little DHEA-S is produced by the gonads, measurement of DHEA-S levels may aid in the localization of androgen source in virilizing conditions [2,3].

  1. Dorfman RI, Shipley RA: Androgens. John Wiley and Sons, New York, 1956, pp. 116-128.
  2. Pang S, Riddick L: Hirsutism. IN Lifshitz F (ed): Pediatric Endocrinology, A Clinical Guide, second edition. Marcel Dekker, Inc., New York, 1990, pp. 259-291.
  3. de Peretti E & Forest MG. J Clin Endocrinol Metab 47:572-577, 1978.
  4. Lee PDK. et al. Pediatrics 76:437-444, 1985.
Info Diagnostic Systems Laboratories, Inc.
Customer Service: (800) 231-7970
Web site: http://www.dslabs.com

Related medicine products :

1. DHEA-S EIA Reproductive Markers 020-DR-1562
2. DHEA-S
3. DHEA-S ELISA
4. DHEA-S-7 (saliva) EIA Test
5. DHEA-S-7 (saliva)
6. DHEA-S-7 EIA Test
7. DHEA-S-7 RIA Test
TAG: DHEA RIA Test
Breaking Medicine Technology:Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3USC researchers identify regulatory genetic sequences that may predict risk for prostate cancer 9582 1NuAire Laboratory Economic Stimulus Package Free Accessories or Factory Options 13569 1Wine May Shield Breast Cancer Patients From Radiation Side Effects 54558 1Wine May Shield Breast Cancer Patients From Radiation Side Effects 54558 2